All News Virax Biolabs Group Limited

Equities

VRAX

KYG9495L1251

Delayed Nasdaq Other stock markets 02:24:37 2024-04-29 pm EDT			5-day change	1st Jan Change
0.64 ^USD	-7.25%		-9.22%	-56.16%

Apr. 25	Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024	CI
Jan. 12	Virax Biolabs Group Limited Reports Earnings Results for the Half Year Ended September 30, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Virax Biolabs : Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024 - Form 6-K	Apr. 25	PU
Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024	Apr. 25	CI
Virax Biolabs to Participate at ESCMID Global 2024	Apr. 17	AQ
Virax Biolabs : to Participate at ESCMID Global 2024 - Form 6-K	Apr. 16	PU
Virax Biolabs : Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency - Form 6-K	Mar. 15	PU
Virax Biolabs Group Limited Reports Earnings Results for the Half Year Ended September 30, 2023	Jan. 12	CI
Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients	Dec. 22	AQ
Virax Biolabs Group Limited Forges Strategic Research Collaboration with University of Manchester and Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients	Dec. 21	CI
Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation	Dec. 15	AQ
Top Premarket Gainers	Dec. 12	MT
Virax Biolabs : Notice of 2023 Annual General Meeting of Shareholders To Be Held on - Form 6-K	Nov. 08	PU
Virax Biolabs : CLAWBACK POLICY - Form 6-K	23-10-31	PU
Virax Biolabs Group Limited announced that it has received $2.15 million in funding	23-10-16	CI
Virax Biolabs Group Limited announced that it expects to receive $2.15 million in funding	23-10-11	CI
Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar	23-09-13	AQ
Virax Biolabs : Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar - Form 6-K	23-09-12	PU
Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum	23-09-04	AQ
Virax Biolabs Group Names Nigel McCracken Operating Chief.	23-09-01	MT
Virax Biolabs Group Limited Announces Management Changes	23-09-01	CI
Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid	23-08-04	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Virax Biolabs Group Limited

Equities

VRAX

KYG9495L1251

All News

Filters